Citigroup Analyst Gives Solid Biosciences a Buy Rating with 16 Price Target
Citigroup analyst David Hoang has just released a report on Solid Biosciences (NASDAQ: SLDB) on March 15, 2024. Hoang has ...
© 2024 Stocks Today
Tag: SLDB
Groundbreaking Licensing Agreement to Develop RNAi Therapy for FSHD
Solid Biosciences and Armatus Bio have joined forces in a groundbreaking licensing agreement on March 7, 2024. This collaboration will ...
Solid Biosciences Inc Receives Orphan Drug Designation for Groundbreaking Gene Therapy to Combat Duchenne Muscular Dystrophy
On January 16, 2024, Solid Biosciences Inc. received an orphan drug designation (ODD) from the U.S. Food and Drug Administration ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Office Real Estate Investment Trusts REITs WellPositioned for ReturntoWork Trend